These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 22184714)

  • 1. ACP Journal Club. Review: Reduced function CYP2C19 genotypes may increase risk for stent clots in patients receiving clopidogrel.
    Wang TY; Granger CB
    Ann Intern Med; 2011 Dec; 155(12):JC6-13. PubMed ID: 22184714
    [No Abstract]   [Full Text] [Related]  

  • 2. ACP Journal Club. Adding omeprazole to clopidogrel reduced GI events and did not increase CV events.
    Chow CK
    Ann Intern Med; 2011 Mar; 154(6):JC3-7. PubMed ID: 21403070
    [No Abstract]   [Full Text] [Related]  

  • 3. Cardiovascular risk in clopidogrel-treated patients according to cytochrome P450 2C19*2 loss-of-function allele or proton pump inhibitor coadministration: a systematic meta-analysis.
    Hulot JS; Collet JP; Silvain J; Pena A; Bellemain-Appaix A; Barthélémy O; Cayla G; Beygui F; Montalescot G
    J Am Coll Cardiol; 2010 Jul; 56(2):134-43. PubMed ID: 20620727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ACP Journal Club. Concomitant use of proton pump inhibitors with clopidogrel may increase risk for readmission after discharge for acute MI.
    Granger CB
    Ann Intern Med; 2009 Aug; 151(4):JC2-13. PubMed ID: 19687487
    [No Abstract]   [Full Text] [Related]  

  • 5. ACP Journal Club. Review: Third-generation P2Y12 inhibitors reduce mortality after PCI more than clopidogrel.
    Hillegass WB
    Ann Intern Med; 2011 Mar; 154(6):JC3-6. PubMed ID: 21403069
    [No Abstract]   [Full Text] [Related]  

  • 6. Paraoxonase-1 Q192R polymorphism and antiplatelet effects of clopidogrel in patients undergoing elective coronary stent placement.
    Trenk D; Hochholzer W; Fromm MF; Zolk O; Valina CM; Stratz C; Neumann FJ
    Circ Cardiovasc Genet; 2011 Aug; 4(4):429-36. PubMed ID: 21685174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ACP Journal Club. Ticagrelor was more effective than clopidogrel, with no increase in major bleeding in acute coronary syndromes.
    Bates ER
    Ann Intern Med; 2009 Dec; 151(12):JC6-4. PubMed ID: 20008753
    [No Abstract]   [Full Text] [Related]  

  • 8. ACP Journal Club. Adding clopidogrel to proton-pump inhibitors was not associated with increased CV risk after MI.
    Aronow HD
    Ann Intern Med; 2010 Dec; 153(12):JC6-13. PubMed ID: 21173402
    [No Abstract]   [Full Text] [Related]  

  • 9. ACP Journal Club. Semuloparin reduced venous thromboembolism in patients receiving chemotherapy for cancer.
    Hull RD
    Ann Intern Med; 2012 Jun; 156(12):JC6-5. PubMed ID: 22711106
    [No Abstract]   [Full Text] [Related]  

  • 10. ACP Journal Club. Increased doses of clopidogrel or aspirin did not prevent cardiovascular events.
    Moliterno DJ
    Ann Intern Med; 2011 Jan; 154(2):JC1-7. PubMed ID: 21242361
    [No Abstract]   [Full Text] [Related]  

  • 11. ACP Journal Club. Ticagrelor was more effective than clopidogrel in acute coronary syndromes with planned invasive treatment.
    Brophy JM
    Ann Intern Med; 2010 May; 152(10):JC5-4. PubMed ID: 20479021
    [No Abstract]   [Full Text] [Related]  

  • 12. ACP Journal Club. Adding clopidogrel to aspirin did not reduce recurrent stroke and increased bleeding in lacunar stroke.
    Manchak M; Holloway R
    Ann Intern Med; 2012 Dec; 157(12):JC6-2. PubMed ID: 23247951
    [No Abstract]   [Full Text] [Related]  

  • 13. ACP Journal Club. An antimicrobial, antithrombotic lock solution reduced catheter-related bloodstream infections in patients receiving dialysis.
    Polkinghorne KR
    Ann Intern Med; 2011 Aug; 155(4):JC2-11. PubMed ID: 21844544
    [No Abstract]   [Full Text] [Related]  

  • 14. ACP Journal Club. Review: Statins do not increase risk for intracerebral hemorrhage.
    Anderson DC
    Ann Intern Med; 2012 Mar; 156(6):JC3-6. PubMed ID: 22431692
    [No Abstract]   [Full Text] [Related]  

  • 15. Prolonged clopidogrel use after bare metal and drug-eluting stent placement: the Veterans Administration drug-eluting stent study.
    Faxon DP; Lawler E; Young M; Gaziano M; Kinlay S
    Circ Cardiovasc Interv; 2012 Jun; 5(3):372-80. PubMed ID: 22668555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ACP Journal Club. Review: Blood pressure-lowering treatments reduce CV morbidity and mortality in patients receiving dialysis.
    Harnett J
    Ann Intern Med; 2009 Jul; 151(2):JC1-6. PubMed ID: 19620150
    [No Abstract]   [Full Text] [Related]  

  • 17. ACP Journal Club. Review: Angiotensin-receptor blockers increase risk for cancer but not cancer-related death.
    Vavalle JP; Newby LK
    Ann Intern Med; 2010 Dec; 153(12):JC6-8. PubMed ID: 21173409
    [No Abstract]   [Full Text] [Related]  

  • 18. ACP Journal Club. Review: Calcium supplements increase risk for myocardial infarction but not mortality or stroke in adults.
    Ensrud KE
    Ann Intern Med; 2010 Nov; 153(10):JC5-7. PubMed ID: 21079214
    [No Abstract]   [Full Text] [Related]  

  • 19. High maintenance dosage of clopidogrel is associated with a reduced risk of stent thrombosis in clopidogrel-resistant patients.
    Tavassoli N; Voisin S; Carrie D; Lapeyre-Mestre M; Galinier M; Montastruc JL; Pathak A
    Am J Cardiovasc Drugs; 2010; 10(1):29-35. PubMed ID: 20104932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ACP Journal Club. Review: Erythropoiesis-stimulating agents targeted to higher hemoglobin levels increase risk for adverse outcomes in CKD.
    Hsu CY
    Ann Intern Med; 2010 Nov; 153(10):JC5-3. PubMed ID: 21079210
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.